Buelent Kocer

Person

Basel, CH

People

Patents Grantslast 30 patents

Information Patent Grant
Piperazine derivatives as MAGL inhibitors
- Patent number 11,390,610
- Issue date Jul 19, 2022
- HOFFMANN-LA ROCHE INC.
- Joerg Benz
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Spiroindolinones as DDR1 inhibitors
- Patent number 10,618,897
- Issue date Apr 14, 2020
- HOFFMANN-LA ROCHE INC.
- Bernd Buettelmann
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Triaza-spirodecanones as DDR1 inhibitors
- Patent number 10,435,407
- Issue date Oct 8, 2019
- Hoffmann-La Roche Inc.
- Bernd Buettelmann
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Triaza-spirodecanones as DDR1 inhibitors
- Patent number 10,239,876
- Issue date Mar 26, 2019
- Hoffman-La Roche Inc.
- Bernd Buettelmann
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
6-bridged heteroaryldihydropyrimidines for the treatment and prophy...
- Patent number 9,758,530
- Issue date Sep 12, 2017
- HOFFMANN-LA ROCHE INC.
- Lei Guo
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
6-bridged heteroaryldihydropyrimidines for the treatment and prophy...
- Patent number 9,266,904
- Issue date Feb 23, 2016
- Hoffmann-La Roche Inc.
- Lei Guo
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE

Patents Applicationslast 30 patents

Information Patent Application
HETEROCYCLIC COMPOUNDS
- Publication number 20200392125
- Publication date Dec 17, 2020
- HOFFMANN-LA ROCHE INC.
- Joerg BENZ
- C07 - ORGANIC CHEMISTRY
Information Patent Application
HETEROCYCLIC COMPOUNDS AS MONOACYLGLYCEROL LIPASE INHIBITORS
- Publication number 20200308190
- Publication date Oct 1, 2020
- HOFFMANN-LA ROCHE INC.
- Charles BELL
- C07 - ORGANIC CHEMISTRY
Information Patent Application
BEZOXAZINE DERIVATIVES USEFUL AS MONOACYLGLYCEROL LIPASE INHIBITORS
- Publication number 20200308158
- Publication date Oct 1, 2020
- HOFFMANN-LA ROCHE INC.
- Charles BELL
- C07 - ORGANIC CHEMISTRY
Information Patent Application
PIPERAZINE DERIVATIVES AS MAGL INHIBITORS
- Publication number 20200299277
- Publication date Sep 24, 2020
- HOFFMANN-LA ROCHE INC.
- Joerg BENZ
- C07 - ORGANIC CHEMISTRY
Information Patent Application
TRIAZA-SPIRODECANONES AS DDR1 INHIBITORS
- Publication number 20190169189
- Publication date Jun 6, 2019
- HOFFMANN-LA ROCHE INC.
- Bernd BUETTELMANN
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
SPIROINDOLINONES AS DDR1 INHIBITORS
- Publication number 20190071444
- Publication date Mar 7, 2019
- HOFFMANN-LA ROCHE INC.
- Bernd Buettelmann
- C07 - ORGANIC CHEMISTRY
Information Patent Application
TRIAZA-SPIRODECANONES AS DDR1 INHIBITORS
- Publication number 20180148450
- Publication date May 31, 2018
- HOFFMANN-LA ROCHE INC.
- Bernd BUETTELMANN
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
NOVEL 6-BRIDGED HETEROARYLDIHYDROPYRIMIDINES FOR THE TREATMENT AND...
- Publication number 20160122363
- Publication date May 5, 2016
- HOFFMANN-LA ROCHE INC.
- Lei Guo
- C07 - ORGANIC CHEMISTRY
Information Patent Application
NOVEL 6-BRIDGED HETEROARYLDIHYDROPYRIMIDINES FOR THE TREATMENT AND...
- Publication number 20140343032
- Publication date Nov 20, 2014
- Hoffmann-La Roche Inc.
- Lei Guo
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE

Buelent Kocer

Person

Patents Grantslast 30 patents

Piperazine derivatives as MAGL inhibitors

Spiroindolinones as DDR1 inhibitors

Triaza-spirodecanones as DDR1 inhibitors

Triaza-spirodecanones as DDR1 inhibitors

6-bridged heteroaryldihydropyrimidines for the treatment and prophy...

6-bridged heteroaryldihydropyrimidines for the treatment and prophy...

Patents Applicationslast 30 patents

HETEROCYCLIC COMPOUNDS

HETEROCYCLIC COMPOUNDS AS MONOACYLGLYCEROL LIPASE INHIBITORS

BEZOXAZINE DERIVATIVES USEFUL AS MONOACYLGLYCEROL LIPASE INHIBITORS

PIPERAZINE DERIVATIVES AS MAGL INHIBITORS

TRIAZA-SPIRODECANONES AS DDR1 INHIBITORS

SPIROINDOLINONES AS DDR1 INHIBITORS

TRIAZA-SPIRODECANONES AS DDR1 INHIBITORS

NOVEL 6-BRIDGED HETEROARYLDIHYDROPYRIMIDINES FOR THE TREATMENT AND...

NOVEL 6-BRIDGED HETEROARYLDIHYDROPYRIMIDINES FOR THE TREATMENT AND...